Skip to main content
News

Issue Brief: March-In Rights Under the Bayh-Dole Act (February 2023)

By February 13, 2023No Comments

Bayh-Dole LogoThe biggest controversy surrounding the Bayh-Dole Act — which allows academic institutions and private contractors to own and manage inventions they make with federal funds — is the false claim that the law allows the government to relicense patents on these inventions to ensure that prices of resulting products are “reasonable.” While this claim has been widely bandied about, it has been rejected by every administration that has considered it for the past 20 years because that’s not how the law works. Still, attempts to undermine Bayh-Dole in this way continue.

{iframe}https://bayhdolecoalition.org/wp-content/uploads/2023/02/BDC-Issue-Brief-March-in-Rights.pdf{/iframe}

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.